Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast

European Journal of Cancer

Volumn 39, Issue 1, 2003, Pages 38-44

  Teo, Nee Beng ^a,b   Shoker, B S ^a   Jarvis, C ^a   Martin, L ^b   Sloane, J P ^a   Holcombe, C ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Breast; Ductal carcinoma in situ; Recurrence

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MICROVASCULATURE; MORPHOMETRICS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MICROCIRCULATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; VON WILLEBRAND FACTOR;

EID: 0037213979     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00248-4     Document Type: Article

References (28)

1. Nemoto T., Vana J., Bedwani R.N., Baker H.W., McGregor F.H., Murphy G.P. Management and survival of female breast cancer. results of a national survey by the American College of Surgeons Cancer. 45:1980;2917-2924.
2. Fryberg E.R., Bland K.I. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer. 74:1994;350-361.
3. Badve S., S'Hern R.P., Ward A.M.et al. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol. 29:1998;915-923.
4. Recht A., Danoff B.S., Solin L.J.et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol. 3:1985;1339-1343.
5. Silverstein M.J., Barth A., Poller D.N.et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 31:1995;1425-1427.
6. Weidner N., Semple J.P., Welch W.R.et al. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
7. Bosari S., Lee A.K.C., DeLellis R.A.et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 23:1992;755-761.
8. Horak E., Leek R., Klerk N.et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 340:1992;1120-1124.
9. Weidner N., Folkman J., Pozza F.et al. Tumour angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 84:1992;1875-1887.
10. Karaiossifidi H., Kouri E., Arvaniti H.et al. Tumour angiogenesis in node-negative breast cancer: relationship with relapse free survival. Anticancer Res. 16:1996;4001-4002.
11. Heimann R., Ferguson D., Powers C.et al. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst. 88:1996;1764-1769.
12. Guidi A.J., Fischer L., Harris J.R., Schnitt S.J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst. 86:1994;614-619.
13. Engels K., Fox S.B., Whitehouse R.M., Gatter K.C., Harris A.L. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol. 181:1997;207-212.
14. Lee A.H.S., Happerfield L.C., Borrow L.G., Millis R.R. Angiogenesis and inflammation in ductal carcinoma in situ of the breast. J Pathol. 181:1997;200-206.
15. Engels K., Fox S.B., Whitehouse R.M., Gatter K.C., Harris A.L. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. J Pathol. 182:1997;414-420.
16. Sales A., Ruiz A., Llombart-Bosch A. Comparative morphometric evaluation of microvessel density and nuclear area in ductal carcinoma in situ and hyperplastic ductal breast lesions. Breast. 8:1999;21-25.
17. Valtola R., Slaven P., Heikkila P.et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol. 154:1999;1381-1390.
18. Lee A.H.S., Dublin E.A., Bobrow L.G. Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast. J Pathol. 187:1999;285-290.
19. Brown L.F., Berse B., Jackman R.W.et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 26:1995;86-91.
20. Guidi A.J., Schnitt S.J., Fischer L. Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 80:1997;1945-1953.
21. National Co-ordinating Group for Breast Screening Pathology. Pathology Reporting in Breast Cancer Screening. NHSBSP Publications No. 3. Sheffield, NHSBSP, 1997, 22-27.
22. The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997; 80: 1798-1802.
23. Martin L., Green B., Renshaw C.et al. Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer. 76:1997;1046-1054.
24. Vermeulen P.B., Verhoeven D., Fierens H.et al. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer. 71:1995;340-343.
25. Vermeulen P.B., Gasparini G., Fox S.B.et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 32A:1996;2474-2484.
26. Ottinetti A., Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat. 11:1988;241-248.
27. Heffelfinger S.C., Yassin R., Miller M.A., Lower E. Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin Cancer Res. 2:1996;1873-1878.
28. Guinebretiere J.M., Monique G.L., Gavoille A., Bahi J., Contesso G. Angiogenesis and risk of breast cancer in women with fibrocystic disease. J Natl Cancer Inst. 86:1994;635-636.